Gilead CSO, COO
Gilead Sciences' Exec VP-Research and Development Norbert Bischofberger will add chief scientific officer to his title, and Chief Financial Officer John Milligan is appointed chief operating officer, the company says March 9. In his new role, Bischofberger will oversee all aspects of Gilead's R&D efforts. Milligan will now manage Gilead's commercial organization, manufacturing, finance and business operations. He will also continue to serve as CFO until a replacement is found...
You may also be interested in...
Use of per- and polyfluoroalkyl substances in cosmetic products appears to be declining, based on voluntary industry registrations with the US Food and Drug Administration. In any event, NGOs are gunning for PFAS' elimination, and the FDA says available data have yet to give a complete safety picture for PFAS used intentionally in cosmetics or present as impurities.
Exec Chat: How Edwards Lifesciences Deploys AI, Remote Monitoring To Help Doctors Make Life-Critical Decisions
Edwards Lifesciences’ head of critical care expects that “smart recovery” AI-driven products will grow the fastest in its critical care unit, which is expected to reach $800m in total revenues for 2021.
I.V. Korsuva now has an August FDA action date, which partner Vifor would commercialize in the ESRD dialysis setting while Cara works toward a broad anti-pruritus label for its oral tablet formulation.